Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Top Pharma List methodology page

  • The Top Pharma List is based on data provided by research and consulting firm GlobalData.
  • The current version of the data ranks companies based on information from GlobalData Pharma Intelligence Center’s Sales Analytics Database, as shown on July 7, 2017.
  • Figures for the period 2018-23 are a forecast, but only show the performance of those companies featured in the 2017 ranking.

US/Japan/Europe Rx

  • These lists rank the top companies based on geographic-specific sales.

Products

  • Product sales are mapped to the parent company, rather than subsidiary companies, as they are reported in the annual reports of the parent company itself.
  • For example, ViiV Healthcare (whose partners include Pfizer and Shionogi) operates as a subsidiary of GSK, so sales for ViiV’s Triumeq have been attributed to GSK.
  • Similarly, Xtandi is attributed to Astellas not Pfizer and Imbruvica is attributed to AbbVie rather than Johnson & Johnson.
  • Finally, sales of Eliquis are reported separately by both Bristol-Myers Squibb and Pfizer and so appears twice in the top product ranking, as does Enbrel with sales as reported by Amgen and Pfizer.

Therapy area sales

  • The sales data provided are not indication-specific where drugs are approved, or in development, for multiple indications. Instead they’re based on GlobalData’s Key Therapy Area classification, which places products into a single therapeutic area based on its corporate positioning and/or mechanism of action.
  • However, product sales may contribute to more than one sales segment, eg biologics and oncology, in which can sales segments for a company may add up to more than its total sales.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...